Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Phenergan — PHENERGAN
Application NDA010926 (NDA)
Phenergan — PHENERGAN
Application NDA011689 (NDA)
Phenergan — PHENERGAN
Application NDA008857 (NDA)
Phenergan — PHENERGAN
Application NDA007935 (NDA)
Kenalog — ARISTOCORT
Application NDA011161 (NDA)
Kenalog — KENACORT
Application NDA011283 (NDA)
Phenergan — PROMETHAZINE HYDROCHLORIDE PLAIN
Application NDA008381 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)